Loading…
Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin
Cisplatin is commonly used in neoadjuvant, adjuvant, and systemic therapy for advanced bladder cancer, but its immune-related mechanism is still unclear. Exploration of the immune effects of cisplatin in bladder cancer would complement the comprehensive mechanism of cisplatin and provide the basis f...
Saved in:
Published in: | Cells (Basel, Switzerland) Switzerland), 2022-09, Vol.11 (19), p.3011 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c525t-634399a7d5e3d34a937aad1367bba3472352d3cb1a0b5b52d9b19cda39e6334b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c525t-634399a7d5e3d34a937aad1367bba3472352d3cb1a0b5b52d9b19cda39e6334b3 |
container_end_page | |
container_issue | 19 |
container_start_page | 3011 |
container_title | Cells (Basel, Switzerland) |
container_volume | 11 |
creator | Fu, Guanghou Wu, Yunfei Zhao, Guanan Chen, Xiaoyi Xu, Zhijie Sun, Junjie Tian, Junjie Cheng, Zhengjun Shi, Yue Jin, Baiye |
description | Cisplatin is commonly used in neoadjuvant, adjuvant, and systemic therapy for advanced bladder cancer, but its immune-related mechanism is still unclear. Exploration of the immune effects of cisplatin in bladder cancer would complement the comprehensive mechanism of cisplatin and provide the basis for combination therapy of cisplatin and immunotherapy in bladder cancer. We confirmed the immune effects of cisplatin on T24 and TCCSUP bladder cancer cell lines in vitro and explored the important function of these immune effects in the bladder cancer microenvironment in a mice tumor model. We found cisplatin induced immune response in bladder cancer by RNA sequencing and validated that cGAS-STING signal was deeply involved in this response. Cisplatin induced cGAS-STING signal inhibited the proliferation of bladder cancer and increased the infiltration percentages of CD8+ T cells and dendritic cells in a transplantation mice tumor model. Accumulation of dsDNA and the release of chromatin bound cGAS are important to activate downstream STING. Our findings indicated a cisplatin-related immune effect in bladder cancer, and cisplatin combined with immunotherapy might have a synergistic effect for bladder cancer therapy. |
doi_str_mv | 10.3390/cells11193011 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_54a8fee49df3435ab3f76ec02da86ec5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A745409952</galeid><doaj_id>oai_doaj_org_article_54a8fee49df3435ab3f76ec02da86ec5</doaj_id><sourcerecordid>A745409952</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-634399a7d5e3d34a937aad1367bba3472352d3cb1a0b5b52d9b19cda39e6334b3</originalsourceid><addsrcrecordid>eNptkk1vEzEQhlcIRKvSI_eVuHDZYnvs3ZgDUohKiFQBUsLZmvVH4mjXDt5Npf57vE1VCMI-zGj8vO9oNC6Kt5TcAEjyQduuGyilEgilL4pLRhqoOCfy5V_5RXE9DHuSz4zWlIjXxQXUDIhs2GUR5nr09zj6GMroSr2cr6v1ZvVtWa79NmBXjrFchZ1v_ViOO1v-SLHzzqZnxecOjbGpXGDQNn0sNxla9f0x2PLWOavHCVr44dBlSXhTvHLYDfb6KV4VP7_cbhZfq7vvy9VifldpwcRY1cBBSmyMsGCAo4QG0VCom7ZF4A0DwQzoliJpRZtz2VKpDYK0NQBv4apYnXxNxL06JN9jelARvXosxLRVmEavO6sEx5mzlkvjcleBLbimtpowg7McRfb6dPI6HNveGm3DmLA7Mz1_CX6ntvFeSVFzgMng_ZNBir-OdhhV74dpdRhsPA6KNUzkFQKnGX33D7qPx5T38EhxRptazP5QW8wD-OBi7qsnUzVvuMg7l4Jl6uY_VL7G9l7HYJ3P9TNBdRLoFIchWfc8IyVq-m_q7L_Bb8YDxOU</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2724217658</pqid></control><display><type>article</type><title>Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Fu, Guanghou ; Wu, Yunfei ; Zhao, Guanan ; Chen, Xiaoyi ; Xu, Zhijie ; Sun, Junjie ; Tian, Junjie ; Cheng, Zhengjun ; Shi, Yue ; Jin, Baiye</creator><creatorcontrib>Fu, Guanghou ; Wu, Yunfei ; Zhao, Guanan ; Chen, Xiaoyi ; Xu, Zhijie ; Sun, Junjie ; Tian, Junjie ; Cheng, Zhengjun ; Shi, Yue ; Jin, Baiye</creatorcontrib><description>Cisplatin is commonly used in neoadjuvant, adjuvant, and systemic therapy for advanced bladder cancer, but its immune-related mechanism is still unclear. Exploration of the immune effects of cisplatin in bladder cancer would complement the comprehensive mechanism of cisplatin and provide the basis for combination therapy of cisplatin and immunotherapy in bladder cancer. We confirmed the immune effects of cisplatin on T24 and TCCSUP bladder cancer cell lines in vitro and explored the important function of these immune effects in the bladder cancer microenvironment in a mice tumor model. We found cisplatin induced immune response in bladder cancer by RNA sequencing and validated that cGAS-STING signal was deeply involved in this response. Cisplatin induced cGAS-STING signal inhibited the proliferation of bladder cancer and increased the infiltration percentages of CD8+ T cells and dendritic cells in a transplantation mice tumor model. Accumulation of dsDNA and the release of chromatin bound cGAS are important to activate downstream STING. Our findings indicated a cisplatin-related immune effect in bladder cancer, and cisplatin combined with immunotherapy might have a synergistic effect for bladder cancer therapy.</description><identifier>ISSN: 2073-4409</identifier><identifier>EISSN: 2073-4409</identifier><identifier>DOI: 10.3390/cells11193011</identifier><identifier>PMID: 36230972</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Bladder cancer ; Cancer ; CD8 antigen ; Cellular signal transduction ; cGAS-STING ; Chemotherapy ; Chromatin ; chromatin bound ; Cisplatin ; Dendritic cells ; DNA damage ; Dosage and administration ; Drug therapy ; Experiments ; Gene expression ; Health aspects ; Immunotherapy ; Lymphocytes T ; Metastases ; Microenvironments ; Patient outcomes ; Transplantation ; Tumor cell lines ; Tumors</subject><ispartof>Cells (Basel, Switzerland), 2022-09, Vol.11 (19), p.3011</ispartof><rights>COPYRIGHT 2022 MDPI AG</rights><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-634399a7d5e3d34a937aad1367bba3472352d3cb1a0b5b52d9b19cda39e6334b3</citedby><cites>FETCH-LOGICAL-c525t-634399a7d5e3d34a937aad1367bba3472352d3cb1a0b5b52d9b19cda39e6334b3</cites><orcidid>0000-0002-6667-0424 ; 0000-0003-4243-3894</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2724217658/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2724217658?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids></links><search><creatorcontrib>Fu, Guanghou</creatorcontrib><creatorcontrib>Wu, Yunfei</creatorcontrib><creatorcontrib>Zhao, Guanan</creatorcontrib><creatorcontrib>Chen, Xiaoyi</creatorcontrib><creatorcontrib>Xu, Zhijie</creatorcontrib><creatorcontrib>Sun, Junjie</creatorcontrib><creatorcontrib>Tian, Junjie</creatorcontrib><creatorcontrib>Cheng, Zhengjun</creatorcontrib><creatorcontrib>Shi, Yue</creatorcontrib><creatorcontrib>Jin, Baiye</creatorcontrib><title>Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin</title><title>Cells (Basel, Switzerland)</title><description>Cisplatin is commonly used in neoadjuvant, adjuvant, and systemic therapy for advanced bladder cancer, but its immune-related mechanism is still unclear. Exploration of the immune effects of cisplatin in bladder cancer would complement the comprehensive mechanism of cisplatin and provide the basis for combination therapy of cisplatin and immunotherapy in bladder cancer. We confirmed the immune effects of cisplatin on T24 and TCCSUP bladder cancer cell lines in vitro and explored the important function of these immune effects in the bladder cancer microenvironment in a mice tumor model. We found cisplatin induced immune response in bladder cancer by RNA sequencing and validated that cGAS-STING signal was deeply involved in this response. Cisplatin induced cGAS-STING signal inhibited the proliferation of bladder cancer and increased the infiltration percentages of CD8+ T cells and dendritic cells in a transplantation mice tumor model. Accumulation of dsDNA and the release of chromatin bound cGAS are important to activate downstream STING. Our findings indicated a cisplatin-related immune effect in bladder cancer, and cisplatin combined with immunotherapy might have a synergistic effect for bladder cancer therapy.</description><subject>Bladder cancer</subject><subject>Cancer</subject><subject>CD8 antigen</subject><subject>Cellular signal transduction</subject><subject>cGAS-STING</subject><subject>Chemotherapy</subject><subject>Chromatin</subject><subject>chromatin bound</subject><subject>Cisplatin</subject><subject>Dendritic cells</subject><subject>DNA damage</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Experiments</subject><subject>Gene expression</subject><subject>Health aspects</subject><subject>Immunotherapy</subject><subject>Lymphocytes T</subject><subject>Metastases</subject><subject>Microenvironments</subject><subject>Patient outcomes</subject><subject>Transplantation</subject><subject>Tumor cell lines</subject><subject>Tumors</subject><issn>2073-4409</issn><issn>2073-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1vEzEQhlcIRKvSI_eVuHDZYnvs3ZgDUohKiFQBUsLZmvVH4mjXDt5Npf57vE1VCMI-zGj8vO9oNC6Kt5TcAEjyQduuGyilEgilL4pLRhqoOCfy5V_5RXE9DHuSz4zWlIjXxQXUDIhs2GUR5nr09zj6GMroSr2cr6v1ZvVtWa79NmBXjrFchZ1v_ViOO1v-SLHzzqZnxecOjbGpXGDQNn0sNxla9f0x2PLWOavHCVr44dBlSXhTvHLYDfb6KV4VP7_cbhZfq7vvy9VifldpwcRY1cBBSmyMsGCAo4QG0VCom7ZF4A0DwQzoliJpRZtz2VKpDYK0NQBv4apYnXxNxL06JN9jelARvXosxLRVmEavO6sEx5mzlkvjcleBLbimtpowg7McRfb6dPI6HNveGm3DmLA7Mz1_CX6ntvFeSVFzgMng_ZNBir-OdhhV74dpdRhsPA6KNUzkFQKnGX33D7qPx5T38EhxRptazP5QW8wD-OBi7qsnUzVvuMg7l4Jl6uY_VL7G9l7HYJ3P9TNBdRLoFIchWfc8IyVq-m_q7L_Bb8YDxOU</recordid><startdate>20220927</startdate><enddate>20220927</enddate><creator>Fu, Guanghou</creator><creator>Wu, Yunfei</creator><creator>Zhao, Guanan</creator><creator>Chen, Xiaoyi</creator><creator>Xu, Zhijie</creator><creator>Sun, Junjie</creator><creator>Tian, Junjie</creator><creator>Cheng, Zhengjun</creator><creator>Shi, Yue</creator><creator>Jin, Baiye</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-6667-0424</orcidid><orcidid>https://orcid.org/0000-0003-4243-3894</orcidid></search><sort><creationdate>20220927</creationdate><title>Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin</title><author>Fu, Guanghou ; Wu, Yunfei ; Zhao, Guanan ; Chen, Xiaoyi ; Xu, Zhijie ; Sun, Junjie ; Tian, Junjie ; Cheng, Zhengjun ; Shi, Yue ; Jin, Baiye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-634399a7d5e3d34a937aad1367bba3472352d3cb1a0b5b52d9b19cda39e6334b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bladder cancer</topic><topic>Cancer</topic><topic>CD8 antigen</topic><topic>Cellular signal transduction</topic><topic>cGAS-STING</topic><topic>Chemotherapy</topic><topic>Chromatin</topic><topic>chromatin bound</topic><topic>Cisplatin</topic><topic>Dendritic cells</topic><topic>DNA damage</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Experiments</topic><topic>Gene expression</topic><topic>Health aspects</topic><topic>Immunotherapy</topic><topic>Lymphocytes T</topic><topic>Metastases</topic><topic>Microenvironments</topic><topic>Patient outcomes</topic><topic>Transplantation</topic><topic>Tumor cell lines</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fu, Guanghou</creatorcontrib><creatorcontrib>Wu, Yunfei</creatorcontrib><creatorcontrib>Zhao, Guanan</creatorcontrib><creatorcontrib>Chen, Xiaoyi</creatorcontrib><creatorcontrib>Xu, Zhijie</creatorcontrib><creatorcontrib>Sun, Junjie</creatorcontrib><creatorcontrib>Tian, Junjie</creatorcontrib><creatorcontrib>Cheng, Zhengjun</creatorcontrib><creatorcontrib>Shi, Yue</creatorcontrib><creatorcontrib>Jin, Baiye</creatorcontrib><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cells (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fu, Guanghou</au><au>Wu, Yunfei</au><au>Zhao, Guanan</au><au>Chen, Xiaoyi</au><au>Xu, Zhijie</au><au>Sun, Junjie</au><au>Tian, Junjie</au><au>Cheng, Zhengjun</au><au>Shi, Yue</au><au>Jin, Baiye</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin</atitle><jtitle>Cells (Basel, Switzerland)</jtitle><date>2022-09-27</date><risdate>2022</risdate><volume>11</volume><issue>19</issue><spage>3011</spage><pages>3011-</pages><issn>2073-4409</issn><eissn>2073-4409</eissn><abstract>Cisplatin is commonly used in neoadjuvant, adjuvant, and systemic therapy for advanced bladder cancer, but its immune-related mechanism is still unclear. Exploration of the immune effects of cisplatin in bladder cancer would complement the comprehensive mechanism of cisplatin and provide the basis for combination therapy of cisplatin and immunotherapy in bladder cancer. We confirmed the immune effects of cisplatin on T24 and TCCSUP bladder cancer cell lines in vitro and explored the important function of these immune effects in the bladder cancer microenvironment in a mice tumor model. We found cisplatin induced immune response in bladder cancer by RNA sequencing and validated that cGAS-STING signal was deeply involved in this response. Cisplatin induced cGAS-STING signal inhibited the proliferation of bladder cancer and increased the infiltration percentages of CD8+ T cells and dendritic cells in a transplantation mice tumor model. Accumulation of dsDNA and the release of chromatin bound cGAS are important to activate downstream STING. Our findings indicated a cisplatin-related immune effect in bladder cancer, and cisplatin combined with immunotherapy might have a synergistic effect for bladder cancer therapy.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>36230972</pmid><doi>10.3390/cells11193011</doi><orcidid>https://orcid.org/0000-0002-6667-0424</orcidid><orcidid>https://orcid.org/0000-0003-4243-3894</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2073-4409 |
ispartof | Cells (Basel, Switzerland), 2022-09, Vol.11 (19), p.3011 |
issn | 2073-4409 2073-4409 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_54a8fee49df3435ab3f76ec02da86ec5 |
source | Publicly Available Content Database; PubMed Central |
subjects | Bladder cancer Cancer CD8 antigen Cellular signal transduction cGAS-STING Chemotherapy Chromatin chromatin bound Cisplatin Dendritic cells DNA damage Dosage and administration Drug therapy Experiments Gene expression Health aspects Immunotherapy Lymphocytes T Metastases Microenvironments Patient outcomes Transplantation Tumor cell lines Tumors |
title | Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T03%3A07%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20cGAS-STING%20Signal%20to%20Inhibit%20the%20Proliferation%20of%20Bladder%20Cancer:%20The%20Immune%20Effect%20of%20Cisplatin&rft.jtitle=Cells%20(Basel,%20Switzerland)&rft.au=Fu,%20Guanghou&rft.date=2022-09-27&rft.volume=11&rft.issue=19&rft.spage=3011&rft.pages=3011-&rft.issn=2073-4409&rft.eissn=2073-4409&rft_id=info:doi/10.3390/cells11193011&rft_dat=%3Cgale_doaj_%3EA745409952%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c525t-634399a7d5e3d34a937aad1367bba3472352d3cb1a0b5b52d9b19cda39e6334b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2724217658&rft_id=info:pmid/36230972&rft_galeid=A745409952&rfr_iscdi=true |